NCT00884260View on ClinicalTrials.gov

GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

PHASE3CompletedINTERVENTIONAL

Enrollment

918

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Contraception

Interventions

DRUG

Levonorgestrel IUS (LCS, BAY86-5028)

In Vitro release rate: 12µg LNG/24h

Trial Locations (25)

2031

Ashfield

3052

Parkville

4029

Herston

6008

Subiaco

100034

Beijing

100191

Beijing

100730

Beijing

116011

Dalian

200011

Shanghai

200025

Shanghai

200127

Shanghai

210008

Nanjing

210009

Nanjing

400010

Chongqing

400042

Chongqing

430030

Wuhan

510405

Guangzhou

610041

Chengdu

Unknown

Nanjing

Jinan

463-712

Sungnam-si

100-380

Seoul

110-744

Seoul

120-752

Seoul

138-736

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY